Corista DP3 ® Platform Receives Class II Medical Device License From Health Canada

DP3's momentum as a world-class integrated pathology solution grows CONCORD, Mass., Feb. 7, 2024 /PRNewswire-PRWeb/ -- Corista, a leader in digital pathology solutions, is excited to announce that it has received a Class II Medical Device License from Health Canada for its DP3 platform....
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: LIC Source Type: news